cis-2,6-dimethylmorpholine-4-sulfonyl chloride | 727989-87-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: cis-2,6-dimethylmorpholine-4-sulfonyl chloride
• 英文别名: (2S,6R)-2,6-dimethylmorpholine-4-sulfonyl chloride
• CAS: 727989-87-9
• 化学式: C₆H₁₂ClNO₃S
• 分子量: 213.685
• InChiKey: IOHUKINMPIUAFU-OLQVQODUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  cis-2,6-dimethylmorpholine-4-sulfonyl chloride 在 吡啶 、 四丁基氟化铵 作用下， 以 四氢呋喃 、 1,2-二氯乙烷 为溶剂， 生成 N-[4-[2-[[(2R)-2-hydroxy-2-(3-pyridinyl)ethyl]amino]2-methylpropyl]phenyl]-2,6-dimethyl-,(2R,6S)-4-morpholinesulfonamide
  参考文献：
  名称：

  Potent and selective, sulfamide-based human β3-adrenergic receptor agonists

  摘要：

  A series of sulfamide-based analogs related to L-796568 were prepared and evaluated for their biological activity at the human beta(3)-adrenergic receptor (AR). This modification allows for a significant reduction in molecular weight, while maintaining single-digit nanomolar potencies at the beta(3)-AR and high selectivities versus the beta(1)- or beta(2)-AR. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.089
• 作为产物：
  描述：

  cis-2,6-dimethylmorpholine 在 4-二甲氨基吡啶 、 磺酰氯 作用下， 以 二氯甲烷 为溶剂， 反应 24.0h， 生成 cis-2,6-dimethylmorpholine-4-sulfonyl chloride
  参考文献：
  名称：

  [EN] OXYCARBAMOYL COMPOUNDS AND THE USE THEREOF
  [FR] COMPOSÉS OXYCARBAMOYLE ET LEUR UTILISATION

  摘要：

  这项发明涉及到化合物的氧羰基化合物的化学式I：该发明还涉及使用化合物的化学式I来治疗、预防或改善对钙通道阻滞有反应的疾病，尤其是N-型钙通道。本发明的化合物特别适用于治疗疼痛。

  公开号：

  WO2009151152A1

文献信息

• [EN] 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS<br/>[FR] 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES ET 4-PYRAZOLYL-N-HÉTÉROARYLPYRIMIDIN-2-AMINES EN TANT QU'INHIBITEURS DE JANUS KINASE
  申请人：INCYTE CORP

  公开号：WO2009064835A1

  公开（公告）日：2009-05-22

  The present invention provides substituted bicyclic heteroaryl compounds, 5 including, for example, 4-pyrazoIyI-N-arylpyrirnidin-2-arnines and 4-pyrazolyl-N-heteroarylpyτimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.formule :(1)

  本发明提供了取代的双环杂环芳基化合物，包括例如4-吡唑基-N-芳基吡啶-2-胺和4-吡唑基-N-杂环芳基嘧啶-2-胺，这些化合物调节激酶的活性，在治疗与激酶活性相关的疾病方面具有用处，例如免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。公式：(1)
• 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS
  申请人：Li Yun-Long

  公开号：US20090318405A1

  公开（公告）日：2009-12-24

  The present invention provides substituted bicyclic heteroaryl compounds, including, for example, 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

  本发明提供了替代的双环杂环芳基化合物，包括例如4-吡唑基-N-芳基嘧啶-2-胺和4-吡唑基-N-杂环芳基嘧啶-2-胺，这些化合物可以调节激酶的活性，对于与激酶活性相关的疾病的治疗具有用处，包括例如免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。
• OXYCARBAMOYL COMPOUNDS AND THE USE THEREOF
  申请人：Mikamiyama Hidenori

  公开号：US20110098276A1

  公开（公告）日：2011-04-28

  The invention relates to oxycarbamoyl compounds of Formula I: The invention is also directed to the use compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.

  本发明涉及式I的氧化氨基甲酰化合物：本发明还涉及使用式I的化合物来治疗、预防或改善对钙通道阻滞有反应的疾病，尤其是N型钙通道。本发明的化合物特别适用于治疗疼痛。
• 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
  申请人：Incyte Corporation

  公开号：US08309718B2

  公开（公告）日：2012-11-13

  The present invention provides substituted bicyclic heteroaryl compounds, including, for example, 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

  本发明提供了取代的双环杂环芳基化合物，包括例如4-吡唑基-N-芳基嘧啶-2-胺和4-吡唑基-N-杂环芳基嘧啶-2-胺，可调节激酶活性，并可用于治疗与激酶活性相关的疾病，包括免疫相关疾病、皮肤疾病、骨髓增生性疾病、癌症和其他疾病。
• Oxycarbamoyl compounds and the use thereof
  申请人：Mikamiyama Hidenori

  公开号：US08518934B2

  公开（公告）日：2013-08-27

  The invention relates to oxycarbamoyl compounds of Formula I: The invention is also directed to the use compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.

  本发明涉及公式I的氧化氨基甲酰化合物。本发明还涉及使用公式I的化合物来治疗、预防或改善对钙通道阻滞有反应的疾病，尤其是N型钙通道。本发明的化合物特别适用于治疗疼痛。